MEDLIVE (02192) announced that on October 15, 2025, it issued 534,500 ordinary shares to one of its directors who exercised stock options under the pre-IPO stock option plan adopted on March 29, 2021.
MEDLIVE (02192) announced that on October 15, 2025, it issued 534,500 ordinary shares to one of its directors who exercised stock options under the pre-IPO stock option plan adopted on March 29, 2021.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.